Company News-Gan & Lee

中文站

Careers | Investors | Patients and HCPS | Contact us

Careers Investors Patients and HCPS Contact us

Search

# Popular search #

Diabetes Oncology Medical Devices

Company News

Company News Exhibitions Activities

All news 2024 2023 2022 2021 2018

Gan & Lee Pharmaceuticals' Fourth-generation Weekly Insulin Preparation GZR4 Completed the First Subject Administration in Phase I Clinical Trial
Gan & Lee 2022-09-01
Gan & Lee Pharmaceuticals Announces Approval of Insulin Aspart in Kazakhstan
Gan & Lee 2022-08-24
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for the innovative once-weekly ultra-long-acting insulin, GZR4
Gan & Lee 2022-08-08
Gan & Lee Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trials of GZR18
Gan & Lee 2022-07-21
Gan & Lee Pharmaceuticals' Insulin Pen and the Pen Needle have been listed in Brazil
Gan & Lee 2022-07-19
Gan & Lee Pharmaceuticals Announces IND Clearance by NMPA for the Ultra-Long Acting Insulin GZR4
Gan & Lee 2022-07-08

Our websites

Gangan Technology

You are now leaving the Gan & Lee website.

The site you are about to visit is maintained by a third party who is responsible for its content.
This link is provided on the Gan & Lee website as a service to our visitors. Gan & Lee is not responsible for the privacy policy of any third-party websites. Gan & Lee encourages visitors to read the privacy policy of every website that you may visit.

Continue Back

Search

Subscribe